Second Sight Reports First Quarter 2017 Financial Results
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-months ended March 31, 2017. First Quarter 2017 and Recent Company Highlights: Increased implant volume to 14 Argus® II Retinal Prosthesis Systems (“Argus II”) worldwide during the first quarter of 2017 compared